HANTAVIRUS & EBOLA — what you need to know →
The Method Why IGMA RUTIN Hantavirus & Ebola
← flu-fighter.com

See what the science says

Hantavirus, Ebola
& Vascular Threats

A review of existing research — not medical advice, not our own studies. We present what scientists have published. You draw your own conclusions.

Both viruses target the same structure.

Both Ebola and hantavirus — particularly the Andes strain — are known to damage the endothelium: the thin layer of cells lining the inside of blood vessels. When this layer is disrupted, vessels begin to leak fluid into surrounding tissues.

Ebola (Escudero-Pérez et al., PLOS Pathogens, 2014): The virus sheds a surface glycoprotein (GP) that activates dendritic cells and macrophages, triggering release of pro-inflammatory cytokines. This directly affects endothelial cell function — increasing vascular permeability. The result: fluid leakage, immune overactivation, and in severe cases, haemorrhagic complications.
Hantavirus: Triggers vascular hyperpermeability through endothelial activation. In severe cases — particularly with the Andes strain — this leads to Hantavirus Pulmonary Syndrome (HPS): fluid accumulating in the lungs, respiratory failure, and circulatory collapse.

The core pathological mechanism in both diseases is the same: the virus increases the permeability of blood vessel walls.

Rutin and vascular permeability.

Rutin is a plant bioflavonoid that has been studied for decades in the context of vascular health. A key study investigated its effect on HMGB1-induced vascular inflammation:

Lee et al., Inflammation Research, 2013: Rutin potently inhibited HMGB1 release, reduced HMGB1-dependent inflammatory responses in human endothelial cells (HUVECs), and inhibited HMGB1-mediated hyperpermeability and leukocyte migration in mice. HMGB1 is a known late mediator of severe vascular inflammatory conditions.

In simple terms: rutin reduced exactly the kind of vascular leakage that both Ebola and hantavirus are known to trigger.

Antiviral activity (PMC11079272): Rutin demonstrated a pronounced inhibitory effect on viral replication at multiple stages of the viral life cycle. The mechanism is linked to the Nrf2/HO-1 signalling pathway — a key antioxidant response system. In vivo studies showed substantial reduction in viral load in lung tissue.

Why ascorbic acid matters here too.

Ascorbic acid is essential for the synthesis of collagen — the structural protein that gives blood vessel walls their strength and integrity. Deficiency in ascorbic acid leads to increased susceptibility of small vessels to haemorrhage and damage.

In the context of viral vascular threats, ascorbic acid plays a supporting role: it helps maintain the structural integrity of vessels that the virus is attempting to destabilise — and it extends the activity of rutin through synergistic interaction.

Two opposing forces.

Factor Ebola / Hantavirus Rutin
Effect on vessel walls Increases permeability Reduces permeability
Endothelium Damages Supports integrity
Inflammation Triggers Inhibits
HMGB1 activity Elevates Suppresses

Two mechanisms. Directly opposing directions.

We leave the implication to you.

Scientific references

Ebola virus — vascular permeability mechanism Escudero-Pérez et al. — Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability — PLOS Pathogens, 2014
ncbi.nlm.nih.gov/pmc/articles/PMC4239094/
Rutin — anti-inflammatory effects on endothelial cells (HMGB1) Lee et al. — Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo — Inflammation Research, 2013
link.springer.com — s00011-013-0689-x
Rutin — antiviral activity via Nrf2/HO-1 pathway ncbi.nlm.nih.gov/pmc/articles/PMC11079272/
Rutin + ascorbic acid — synergistic antioxidant activity Milde et al. — Synergistic inhibition of low-density lipoprotein oxidation by rutin, gamma-terpinene, and ascorbic acid — Phytomedicine, 2004
Ascorbic acid — role in vascular integrity sciencedirect.com — S0022316623072644
This page presents a review of published scientific research. It does not constitute medical advice and does not claim that any supplement treats, prevents, or cures any disease.
© 2026 Flu-Fighter.com